Latest Europe News

Page 9 of 133
Cynata Therapeutics is on the cusp of releasing critical data from its Phase 2 aGvHD and Phase 3 osteoarthritis trials in Q2 2026, while managing a tight cash runway and preparing for a capital raising.
Ada Torres
Ada Torres
30 Apr 2026
Black Rock Mining is closing in on full construction readiness at its Mahenge Graphite Project after completing key early works and advancing funding discussions amid improving graphite prices.
Maxwell Dee
Maxwell Dee
30 Apr 2026
ReNerve Limited reports a 79% jump in quarterly sales, secures key Asia-Pacific approvals, and progresses its nerve repair pipeline with the NervAlign Nerve Guide Matrix entering Stage 3 development.
Ada Torres
Ada Torres
30 Apr 2026
Little Green Pharma (ASX:LGP) posted record quarterly and annual revenues driven by a surge in European sales, improved cashflow, and reduced debt. The company is on track to complete its merger with Cannatrek by June 1, 2026, while benefiting from the US rescheduling of medicinal cannabis to Schedule III.
Ada Torres
Ada Torres
30 Apr 2026
Epsilon Healthcare has achieved its highest quarterly receipts ever with $3.14 million in Q1 2026, driven by strong expansion across contract manufacturing, clinics, and pharmacy operations.
Ada Torres
Ada Torres
30 Apr 2026
4DMedical has made significant strides in commercial adoption of its CT:VQ™ lung imaging technology, securing top US hospital contracts, regulatory approvals in Europe and the UK, and a major pharmaceutical partnership, all backed by strong capital raises and inclusion in the S&P/ASX 200.
Ada Torres
Ada Torres
30 Apr 2026
Sarytogan Graphite Limited has received $1.4 million from the European Bank for Reconstruction and Development, boosting funds for its Definitive Feasibility Study and advancing its strategic graphite project in Kazakhstan.
Maxwell Dee
Maxwell Dee
30 Apr 2026
Yugo Metals (ASX:YUG) secured government approval for its Petrovo tenement in Bosnia, while initial drilling at Sinjakovo’s Kovacevac and Erak prospects delivered promising polymetallic results. The company also appointed Petar Tomašević as permanent CEO, positioning itself for further exploration progress.
Maxwell Dee
Maxwell Dee
30 Apr 2026
Optiscan Imaging has submitted its FDA dossier for InSpecta®, marking a crucial step toward US veterinary market entry, while progressing clinical studies for InVue® and InForm® ahead of further FDA submissions in 2026.
Ada Torres
Ada Torres
30 Apr 2026
Control Bionics progresses its scalable distributor-led model in North America, inks a strategic US partnership for iOS speech devices, and gains German reimbursement eligibility for NeuroNode, while managing cash flow amid NDIS delays.
Victor Sage
Victor Sage
30 Apr 2026
dorsaVi has launched a multi-year partnership with Taiwan’s ITRI and NTU to develop its proprietary RRAM platform at the 22-nm node, complemented by a new advisory board and neuromorphic IP acquisition, positioning the company at the forefront of ultra-edge AI hardware.
Sophie Babbage
Sophie Babbage
30 Apr 2026
BlinkLab has completed onboarding all clinical sites for its pivotal FDA autism trial, enrolled the first participant, and launched a nationwide autism screening program in Morocco. A recent A$17.7 million capital raise will fund further trials and expansion into ADHD diagnostics.
Ada Torres
Ada Torres
30 Apr 2026